FDA NDC Directory · JSON-LD · Markdown

posaconazole

NDC 0054-0449 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA208773
Dosage form / routeSUSPENSION · ORAL
Active ingredientsPOSACONAZOLE (40 mg/mL)
Marketing started20230329
Package count1

External sources

Source: openFDA. Public-domain (CC0).